Prestige Consumer Healthcare Beneish M-Score Historical Data
The historical data trend for Prestige Consumer Healthcare's Beneish M-Score can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Prestige Consumer Healthcare Beneish M-Score Chart
|
Prestige Consumer Healthcare Annual Data
|
|
Trend |
Mar14 |
Mar15 |
Mar16 |
Mar17 |
Mar18 |
Mar19 |
Mar20 |
Mar21 |
Mar22 |
Mar23 |
| Beneish M-Score |
|
Get a 7-Day Free Trial
|
|
|
-2.93 |
-2.42 |
-2.72 |
-2.34 |
-2.22 |
|
Prestige Consumer Healthcare Quarterly Data
|
|
Mar19 |
Jun19 |
Sep19 |
Dec19 |
Mar20 |
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
| Beneish M-Score |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
-2.33 |
-2.22 |
-2.29 |
-2.28 |
-2.29 |
Competitive Comparison of Prestige Consumer Healthcare's Beneish M-Score
For the Drug Manufacturers - Specialty & Generic subindustry, Prestige Consumer Healthcare's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Prestige Consumer Healthcare's Beneish M-Score Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Prestige Consumer Healthcare's Beneish M-Score distribution charts can be found below:
* The bar in red indicates where Prestige Consumer Healthcare's Beneish M-Score falls into.
Prestige Consumer Healthcare Beneish M-Score Calculation
The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.
The M-Score Variables:
The M-score of Prestige Consumer Healthcare for today is based on a combination of the following eight different indices:
| M | = | -4.84 | + | 0.92 * DSRI | + | 0.528 * GMI | + | 0.404 * AQI | + | 0.892 * SGI | + | 0.115 * DEPI |
| = | -4.84 | + | 0.92 * 1.0823 | + | 0.528 * 1.0131 | + | 0.404 * 0.9889 | + | 0.892 * 0.9959 | + | 0.115 * 0.9921 |
| - | 0.172 * SGAI | + | 4.679 * TATA | - | 0.327 * LVGI |
| - | 0.172 * 0.9633 | + | 4.679 * 0.014642 | - | 0.327 * 0.9365 |
| = | -2.31 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
| This Year (Dec23) TTM: | Last Year (Dec22) TTM: |
Total Receivables was €160 Mil.
Revenue was 259.273 + 268.278 + 257.802 + 267.002 = €1,052 Mil.
Gross Profit was 144.829 + 149.939 + 142.763 + 143.616 = €581 Mil.
Total Current Assets was €361 Mil.
Total Assets was €3,063 Mil.
Property, Plant and Equipment(Net PPE) was €76 Mil.
Depreciation, Depletion and Amortization(DDA) was €28 Mil.
Selling, General, & Admin. Expense(SGA) was €236 Mil.
Total Current Liabilities was €117 Mil.
Long-Term Debt & Capital Lease Obligation was €1,106 Mil.
Net Income was 48.643 + 50.185 + 49.174 + -224.676 = €-77 Mil.
Non Operating Income was -0.625 + -0.215 + 1.143 + -345.361 = €-345 Mil.
Cash Flow from Operations was 65.54 + 58.525 + 44.384 + 55.094 = €224 Mil.
|
Total Receivables was €148 Mil.
Revenue was 260.095 + 292.166 + 262.098 + 242.378 = €1,057 Mil.
Gross Profit was 141.979 + 162.619 + 151.473 + 135.167 = €591 Mil.
Total Current Assets was €386 Mil.
Total Assets was €3,540 Mil.
Property, Plant and Equipment(Net PPE) was €86 Mil.
Depreciation, Depletion and Amortization(DDA) was €32 Mil.
Selling, General, & Admin. Expense(SGA) was €246 Mil.
Total Current Liabilities was €151 Mil.
Long-Term Debt & Capital Lease Obligation was €1,358 Mil.
|
1. DSRI = Days Sales in Receivables Index
Measured as the ratio of Revenue in Total Receivables in year t to year t-1.
A large increase in DSR could be indicative of revenue inflation.
| DSRI | = | (Receivables_t / Revenue_t) | / | (Receivables_t-1 / Revenue_t-1) |
| = | (159.822 / 1052.355) | / | (148.284 / 1056.737) |
| = | 0.151871 | / | 0.140323 |
| | = | 1.0823 |
2. GMI = Gross Margin Index
Measured as the ratio of gross margin in year t-1 to gross margin in year t.
Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.
| GMI | = | GrossMargin_t-1 | / | GrossMargin_t |
| = | (GrossProfit_t-1 / Revenue_t-1) | / | (GrossProfit_t / Revenue_t) |
| = | (591.238 / 1056.737) | / | (581.147 / 1052.355) |
| = | 0.559494 | / | 0.552235 |
| | = | 1.0131 |
3. AQI = Asset Quality Index
AQI is the ratio of asset quality in year t to year t-1.
Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.
| AQI | = | (1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) | / | (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1) |
| = | (1 - (361.102 + 76.347) / 3062.554) | / | (1 - (385.952 + 85.756) / 3539.787) |
| = | 0.857162 | / | 0.866741 |
| | = | 0.9889 |
4. SGI = Sales Growth Index
Ratio of Revenue in year t to sales in year t-1.
Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.
| SGI | = | Sales_t | / | Sales_t-1 |
| = | Revenue_t | / | Revenue_t-1 |
| = | 1052.355 | / | 1056.737 |
| | = | 0.9959 |
5. DEPI = Depreciation Index
Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.
DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.
| DEPI | = | (Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) | / | (Depreciation_t / (Depreciaton_t + PPE_t)) |
| = | (31.64 / (31.64 + 85.756)) | / | (28.478 / (28.478 + 76.347)) |
| = | 0.269515 | / | 0.271672 |
| | = | 0.9921 |
Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.
6. SGAI = Sales, General and Administrative expenses Index
The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.
SGA expenses index > 1 means that the company is becoming less efficient in generate sales.
| SGAI | = | (SGA_t / Sales_t) | / | (SGA_t-1 /Sales_t-1) |
| = | (235.637 / 1052.355) | / | (245.623 / 1056.737) |
| = | 0.223914 | / | 0.232435 |
| | = | 0.9633 |
7. LVGI = Leverage Index
The ratio of total debt to Total Assets in year t relative to yeat t-1.
An LVGI > 1 indicates an increase in leverage
| LVGI | = | ((LTD_t + CurrentLiabilities_t) / TotalAssets_t) | / | ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1) |
| = | ((1105.602 + 116.86) / 3062.554) | / | ((1357.507 + 151.206) / 3539.787) |
| = | 0.399164 | / | 0.426216 |
| | = | 0.9365 |
8. TATA = Total Accruals to Total Assets
Total accruals calculated as the change in working capital accounts other than cash less depreciation.
| TATA | = | (IncomefromContinuingOperations_t | - | CashFlowsfromOperations_t) | / | TotalAssets_t |
| = | (NetIncome_t - NonOperatingIncome_t | - | CashFlowsfromOperations_t) | / | TotalAssets_t |
| = | (-76.674 - -345.058 | - | 223.543) | / | 3062.554 |
| | = | 0.014642 |
An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.
Prestige Consumer Healthcare has a M-score of -2.31 suggests that the company is unlikely to be a manipulator.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
FRA:PBV has been successfully added to your